Clinical Trial Update: Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Prismocitrate 18 for regional citrate anticoagulation during acute continuous renal replacement therapy in patients with acute kidney i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Prismocitrate 18

Snippet

Sponsor: Vantive Health LLC | Conditions: Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Status: TERMINATED | Results posted: 2021-01-05